Charco Neurotech, established in 2019 by Lucy Jung and Floyd Pierres, was founded with one ambition: to bring back smiles for people with Parkinson’s. Parkinson’s is a neurodegenerative disorder affecting 10 million people worldwide. Despite the best available medical interventions, people with Parkinson’s often remain significantly limited in their activities. This led to our design of the CUE1, a non-invasive wearable device. The CUE1 alleviates certain Parkinson’s symptoms, including stiffness and slowness of movement. It achieves this by utilising two vibration-based therapies: focused stimulation and cueing, both of which are research-validated. It also incorporates discreet medication reminders and an accompanying app, which enable the user to track their symptoms. During our pilot testing of the CUE1, we have consistently recorded average improvements during use of the device, with participants reporting smoother and quicker movements. Through these innovations, we hope to improve quality of life for all with Parkinson’s.